InsiderTrades

Form 4 for PAYO Payoneer Global Inc.

Accepted 2022-11-02 00:00:00 ET · period of report 2022-11-01 · accession 0000950103-22-019078 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-02 2022-11-01 PAYO Perry Itai SVP Fin M - OptEx $2.87 +5,700 91.9K +7% +$16.4K
D 2022-11-02 2022-11-01 PAYO Perry Itai SVP Fin S - Sale+OE $8.00 -6,200 86.7K -7% -$49.6K
DM 2022-11-02 2022-11-01 PAYO Perry Itai SVP Fin M - OptEx $0.00 -5,700 12.8K -31% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-01 M A 1,000 $2.74 92,942 D — — (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
2 Common Common Stock 2022-11-01 M A 4,700 $2.90 91,942 D — — (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
3 Common Common Stock 2022-11-01 S D 6,200 $8.00 86,742 D — — (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
4 Derivative Stock Options (Right to buy) 2022-11-01 M D 4,700 $0.00 39,913 D $2.90 · — to 2029-04-30 3,700 Common Stock (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F2) Option vests over 4 years, beginning on 4/30/2019, subject to the Reporting Person's continued employment with the Issuer. The reported portion is fully vested and immediately exercisable.
5 Derivative Stock Options (Right to buy) 2022-11-01 M D 1,000 $0.00 12,790 D $2.74 · — to 2030-03-19 750 Common Stock (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F3) Option vests over 4 years, beginning on 3/19/2020, subject to the Reporting Person's continued employment with the Issuer. The reported portion is fully vested and immediately exercisable.